Healthlead PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,229	1,977	1,636	1,520	1,199
Other Revenue	41.07	34.35	23.77	18.69	17.62
Revenue	2,270	2,011	1,659	1,538	1,216
Revenue Growth (YoY)	12.85%	21.22%	7.87%	26.46%	12.63%
Cost of Revenue	1,686	1,512	1,258	1,143	922.42
Gross Profit	583.49	499.1	400.98	394.95	293.95
Selling, General & Admin	480.85	410.04	306.94	249.52	191.31
Other Operating Expenses	-7.93	-6.33	-6.68	-2.97	-
Operating Expenses	472.92	403.71	300.26	246.55	191.31
Operating Income	110.57	95.39	100.72	148.39	102.64
Interest Expense	-16.59	-13.61	-8.98	-5.73	-5.34
Interest & Investment Income	4.68	8.02	2.87	0.17	0.04
Other Non Operating Income (Expenses)	-0.17	0.21	-0.57	-	-
EBT Excluding Unusual Items	98.5	90	94.04	142.83	97.35
Gain (Loss) on Sale of Assets	-	6.45	-	-	-
Pretax Income	98.5	96.46	94.04	142.83	97.35
Income Tax Expense	20.64	18.19	19.36	24.61	17.68
Net Income	77.86	78.26	74.68	118.23	79.66
Net Income to Common	77.86	78.26	74.68	118.23	79.66
Net Income Growth	-0.52%	4.80%	-36.84%	48.41%	52.98%
Shares Outstanding (Basic)	268	272	272	272	206
Shares Outstanding (Diluted)	268	272	272	272	206
Shares Change (YoY)	-1.29%	-	-	31.84%	27.46%
EPS (Basic)	0.29	0.29	0.27	0.43	0.39
EPS (Diluted)	0.29	0.29	0.27	0.43	0.39
EPS Growth	0.79%	4.80%	-36.84%	12.57%	20.02%
Free Cash Flow	161.05	14.2	9.72	16.07	72.44
Free Cash Flow Per Share	0.60	0.05	0.04	0.06	0.35
Dividend Per Share	0.220	0.170	0.150	0.180	0.280
Dividend Growth	29.41%	13.33%	-16.67%	-35.71%	300.00%
Gross Margin	25.70%	24.81%	24.16%	25.68%	24.17%
Operating Margin	4.87%	4.74%	6.07%	9.65%	8.44%
Profit Margin	3.43%	3.89%	4.50%	7.69%	6.55%
Free Cash Flow Margin	7.09%	0.71%	0.59%	1.04%	5.96%
EBITDA	153.46	131.3	126.32	162.96	117.12
EBITDA Margin	6.76%	6.53%	7.61%	10.59%	9.63%
D&A For EBITDA	42.89	35.92	25.6	14.57	14.48
EBIT	110.57	95.39	100.72	148.39	102.64
EBIT Margin	4.87%	4.74%	6.07%	9.65%	8.44%
Effective Tax Rate	20.95%	18.86%	20.58%	17.23%	18.16%
Revenue as Reported	2,270	2,018	1,659	1,538	1,216

Source: S&P Global Market Intelligence. Standard template. Financial Sources.